R&D Trends

AVROBIO awarded Johnson & Johnson JLabs Incubator Space

Monday, May 16, 2016

AVROBIO, a clinical-stage biotechnology company developing transformative, life-changing gene therapies targeting rare diseases and cancer, has been awarded lab space at Johnson & Johnson’s (J&J) newest JLABS facility in Toronto, Ontario. AVROBIO, headquartered in Cambridge, Massachusetts, with researchers in Toronto, will join other early stage companies in the 40,000 square foot facility opening this spring.

[Read More]

DCRI, SAS open heart-disease data to researchers

Monday, May 9, 2016

A new collaboration between the Duke Clinical Research Institute (DCRI) and SAS will give more researchers access to the largest and oldest cardiovascular database in the world. The DCRI and analytics leader SAS will provide researchers worldwide with data management and analytics tools to explore 45 years of cardiovascular patient data collected by the Duke University Health System.

[Read More]

WAVE, Pfizer partner on metabolic diseases

Thursday, May 5, 2016

WAVE Life Sciences has entered into a research, license and option agreement with Pfizer for the potential development of nucleic acid therapies aimed at silencing the underlying causes of debilitating metabolic diseases. The collaboration will focus on genetically defined targets and bring together WAVE’s proprietary stereopure drug development platform, across antisense and RNAi modalities, along with GalNAc and Pfizer’s hepatic targeting technology for enhanced delivery to the liver.

[Read More]

EMD Serono expands biopharmaceutical R&D facility in Massachusetts

Tuesday, May 3, 2016

EMD Serono, the biopharmaceutical business of Merck, Darmstadt, Germany, in North America, has announced a $12 million investment for the expansion of its R&D facility in Billerica, Massachusetts. The new building will span more than 30,000 square feet and accommodate approximately 120 new and current employees whose focus will be on accelerating innovation in R&D, with a focus on oncology, immuno-oncology and immunology.

[Read More]